Politicians in Punjab have renewed calls for a zero-tolerance approach to the drug market, but escalating harms necessitate a reorientation towards harm reduction and human rights.
This webinar aims to present updates on developments in decriminalisation around the world, the backlash in Oregon (US), British Columbia (Canada) and Porto (Portugal), and to discuss their impacts on drug policy and advocacy in Asia.
IDPC joins over 30 organisations worldwide calling for a stop to the Yukthiya operation, the end of compulsory centres and arbitrary detention, and resources for evidence-based treatment and care.
Policing issues, ambiguity in regulatory policies, and lack of infrastructure to measure beneficial use hinders the exploration of cannabis for its medicinal properties.
While the longer-term impacts of the ban on the global heroin supply will greatly depend on potential subsequent bans on cultivation and trade, the livelihoods of thousands of landless labourers are in danger.
Mainline review the current harm reduction programmes in Nepal from the perspective of women who inject drugs, and formulate recommendations to improve service delivery.
While it is not yet clear whether the Taliban's opium ban will remain, policymakers must consider the huge risk of increased overdose deaths in Europe if the heroin supply does dry up, and urgently begin contingency planning and delivery of interventions.
Youth-led organisations are mobilising to demand more accessible treatment and harm reduction programmes, and to put an end to criminalisation and state violence.
HRI's twelfth report documents the drastic increase of drug-related executions that have taken place over the course of 2022, the inadequate responses of institutional actors, and the robust resistance of civil society.
